SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001395064-19-000029
Filing Date
2019-09-10
Accepted
2019-09-10 06:21:05
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC 13G sc13g_091019.htm SC 13G 73875
2 EXHIBIT 99.1 exhibit991.htm EX-99.1 2659
3 EXHIBIT 99.2 exhibit992.htm EX-99.2 10217
  Complete submission text file 0001395064-19-000029.txt   88227
Mailing Address 1-1, DOSCHOMACHI 4-CHOME CHUO-KU, OSALCA 540-8645 M0 00000
Business Address 1-1, DOSCHOMACHI 4-CHOME CHUO-KU, OSALCA 540-8645 M0 00000
TAKEDA PHARMACEUTICAL CO LTD (Filed by) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations

Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Subject) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91075 | Film No.: 191084250
SIC: 2834 Pharmaceutical Preparations